IPO Detail
Avience Biomedicals Limited
SMENot investment advice. Read RHP before applying.
Price Band
₹196 – ₹208
GMP (Indicative)
—
Unofficial · not guaranteed
Lot Size
600 shares
Status
Listed
Open Date
2026-06-18
Close Date
2026-06-22
Listing Date
2026-06-25
Min. Investment
₹1,24,800
Overview
About the Company
Avience Biomedicals Limited is a Noida-based healthcare company engaged in manufacturing, marketing and supplying molecular diagnostics products, in-vitro diagnostic (IVD) kits, medical devices, laboratory consumables, serology products, biochemistry analysers and reagents. The company focuses on affordable diagnostic solutions and has over two decades of domain experience through its management team. It serves hospitals, laboratories, distributors and government healthcare institutions across India.
New to IPO analysis? You may review our structured guides on how IPO allotment works and IPO subscription meaning to better understand demand and allocation mechanics.
Financials
Key Financial Metrics
EPS Pre IPO
12.72
EPS Post IPO
—
P/E Pre
16.35
P/E Post
—
ROCE
37.65%
Debt / Equity
0.32
PAT Margin
17.4%
Market Cap
114.09
Financial figures sourced from official offer documents. Always verify with the RHP.
Issue
IPO Issue Details
Issue Price
₹196 – ₹208
Face Value
₹10
Issue Size
30.24
Fresh Issue
30.24
Listing At
NSE (SME)
Lead Manager
Fintellectual Corporate Advisors Pvt. Ltd.
Registrar
Skyline Financial Services Pvt. Ltd.
Lot Size
600
For category-wise quota breakdown such as QIB, HNI, and Retail allocation, refer to our IPO quota structure explanation.
Investors
Anchor Investors
4,09,800 shares reserved for Anchor Investors (individual names not publicly disclosed in retrieved sources)
SME Specific
Market Maker Details
Market Maker Shares Offered
—
Market Maker Reservation (%)
—
Applicable only for SME IPOs where a market maker is appointed to provide liquidity post listing.
GMP (Grey Market Premium)
GMP Overview
—
Updated —
Issue price comparison unavailable
GMP is unofficial and indicative only. It does not guarantee listing price or returns.
GMP is unofficial and indicative. To understand interpretation logic and limitations, read our IPO Grey Market Guide or begin with what IPO GMP means.
Trend
GMP Trend
No GMP data yet. Updates will appear once available.
Investment
Market Lot Details
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 600 | 124800 |
| Retail (Max) | 1 | 600 | 124800 |
| sNII (Min) | — | — | — |
| bNII (Min) | — | — | — |
| sNII (Max) | 8 | 4800 | 998400 |
| bNII (Max) | — | — | — |
Investors can bid in multiples of the lot size. Final investment depends on the cutoff price.
Valuation
IPO Valuation Metrics
EPS Pre IPO
12.72
EPS Post IPO
—
P/E Pre
16.35
P/E Post
—
ROCE
37.65%
Debt/Equity
0.32
RoNW
—
PAT Margin
17.4%
Market Cap
114.09
Contacts
Company & Registrar Details
Company Address: C-11, Block-C, Community Centre, Janakpuri, New Delhi – 110058
Phone: 1800-120-4636
Email: info@avienbio.com
Website: https://avienbio.com
Registrar: Skyline Financial Services Pvt. Ltd.
Registrar Phone: +91-11-40450193 to 97
Registrar Email: ipo@skylinerta.com
Registrar Website: https://www.skylinerta.com
Issue Summary
Objectives of Issue
Working capital requirements Capital expenditure General corporate purposes Strengthening manufacturing capacity
Ownership
Promoter Holdings
Pre Issue
92.85%
Post Issue
66.37%
Allocation
Reservation Details
QIB
50
NII
15
RII
35
Employee
—
Documents
Important Links
Performance
Listing Performance
Listing Exchange
NSE (SME)
Listing Price
₹395.2
Listing Gain
90%
Qualitative Factors
Strengths & Risks
Company Strengths
Growing molecular diagnostics business Wide portfolio of IVD and laboratory products Modern manufacturing facility in Noida Strong relationships with hospitals and laboratories Experienced promoter group Healthy financial growth
Company Risks
Highly competitive diagnostics industry Dependence on government and institutional orders Regulatory approvals for medical products Working capital intensive operations Technology changes may require continuous investment
Schedule
Timeline
Open Date
2026-06-18
Close Date
2026-06-22
Allotment Date
2026-06-23
Refund Date
2026-06-24
Listing Date
2026-06-25
Legal Disclaimer
Information is sourced from publicly available exchange filings and company offer documents. GMP is unofficial and indicative. IPOCraft does not provide investment advice.
Subscription
Live Subscription Details
| Day | QIB | NII | sNII (< ₹10L) | bNII (> ₹10L) | Retail | Total |
|---|---|---|---|---|---|---|
| 2026-06-22 | 196.77x | 597.23x | —x | —x | 401.21x | 385.24x |
Subscription Progress
Subscription data sourced from exchange updates. Values represent times subscribed (x).
Learn how subscription categories are allocated by reading our guide on QIB, HNI and Retail IPO quota structure.
If you are tracking GMP alongside subscription demand, see our grey market premium guide for a structured comparison framework.
Application
How to Apply
UPI Method (ASBA)
Log in to your broker's app or net banking, navigate to the IPO section, select this IPO, enter lot quantity, and authorise via UPI mandate. Funds are blocked, not debited, until allotment.
ASBA via Net Banking
Log in to your bank's net banking portal, go to the IPO / ASBA section, fill in the bid details, and submit. Your bank will block the required amount automatically.
Allotment & Refund
Allotment status is typically available within 6 days of the IPO close date. Refunds for unallotted bids are credited within 2 working days post allotment.
You may also review the complete IPO allotment process explanation to understand lottery mechanics and refund timelines.
Risk Disclosure
Investments in IPOs are subject to market risks. Grey Market Premium (GMP) is unofficial and indicative only — it does not guarantee listing price or returns. Read the official offer documents (DRHP / RHP) and consult a SEBI-registered financial advisor before applying. IPOCraft does not provide investment advice.
Research Before You Apply